Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Inflammatory Bowel Disease
100%
Cumulative Exposure
100%
Immunomodulator
100%
Cervical Neoplasia
100%
CIN2+
88%
Biological Agents
66%
Risk Factors
22%
Immunosuppressive Drugs
22%
Immunosuppressive Agents
22%
Dutch
11%
Patient Characteristics
11%
Cervical Cancer
11%
Incidence Rate
11%
Counseling
11%
Biobank
11%
Years of Exposure
11%
Multivariate Analysis
11%
Cyclosporine
11%
Cox Regression Model
11%
Thiopurines
11%
Methotrexate
11%
Cervical Cancer Screening
11%
Adult Women
11%
Tacrolimus
11%
Time-dependent Cox Regression
11%
Anti-tumor Necrosis Factor (anti-TNF)
11%
Cytopathology
11%
Vedolizumab
11%
Ustekinumab
11%
Screening Frequency
11%
Biologic Immunomodulators
11%
High-grade Cervical Intraepithelial Neoplasia
11%
INIS
diseases
100%
women
100%
risks
100%
inflammation
100%
screening
33%
patients
22%
immunosuppressive drugs
22%
detection
11%
cancer
11%
comparative evaluations
11%
assessments
11%
adults
11%
multivariate analysis
11%
tumor necrosis factor
11%
time dependence
11%
cyclosporine
11%
methotrexate
11%
Medicine and Dentistry
Neoplasm
100%
Immunomodulating Agent
100%
Inflammatory Bowel Disease
100%
Biological Product
66%
Immunosuppressive Drug
22%
Cohort Analysis
11%
Tumor Necrosis
11%
Multivariate Analysis
11%
Counseling
11%
Tacrolimus
11%
Cyclosporine
11%
Proportional Hazards Model
11%
Methotrexate
11%
Mercaptopurine
11%
Cytopathology
11%
Cervical Cancer
11%
Cervical Intraepithelial Neoplasia
11%
Cervical Screening
11%
Ustekinumab
11%
Vedolizumab
11%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Inflammatory Bowel Disease
100%
Immunomodulating Agent
100%
Biological Product
66%
Immunosuppressive Agent
22%
Cohort Study
11%
Tumor Necrosis
11%
Ciclosporin
11%
Tacrolimus
11%
Mercaptopurine
11%
Methotrexate
11%
Uterine Cervix Cancer
11%
Uterine Cervix Carcinoma in Situ
11%
Ustekinumab
11%
Vedolizumab
11%
Immunology and Microbiology
Inflammatory Bowel Disease
100%
Immunomodulating Drugs
100%
Biological Product
66%
Immunosuppressive Drug
22%
Tumor Necrosis Factor Alpha
11%
Ciclosporin
11%
Tacrolimus
11%
Methotrexate
11%
Vedolizumab
11%
Ustekinumab
11%